News
Oculogica in the news
New Roadside Cannabis Test piloted across U.S.
Neuro-diagnostic company Oculogica today announced the launch of OcuPro, the fastest roadside cannabis test with immediate results, and pilots with several police departments across the U.S.. Officers …
New device can diagnose concussions using AI
Founder, Dr. Uzma Samadani is featured in a story by Sarah Philip at Leaps.org. Click here to read the full article. Using eye movements to …
Oculogica publishes 5-site study on FDA cleared Concussion Diagnostic
Oculogica Inc. announces publication of the initial 5-site study performed to obtain FDA Marketing Authorization for its EyeBOX technology as an aid in the diagnosis of …
Without Updated Tools, NFL still finding Concussions too late
Oculogica Founder Dr. Uzma Samadani is featured in a story Elena Bergeron at the NY Times. Clickhere to read the full article. Concussions can cause …
Sisters get Concussion Diagnostic funded, FDA approved and reimbursed
CEO Rosina Samadani is featured in a story by Geri Stengel at Forbes. Click here to read the fullarticle. Two sisters teamed up to develop …
The Packers are the only N.F.L. team whose fans can buy an ownership stake
Oculogica is featured in a story by Ken Belson at the New York Times. Click here to read. Among the offices facing Lambeau Field are those of …
Oculogica promotes Justin Johnson to Vice President of Commercial Development
Oculogica, a leader in concussion diagnostics, announces that Justin Johnson has been promoted to the role of Vice President of Commercial Development. Justin has an …
Oculogica Partners with St. Paul-based Minnetronix Medical
March 8, 2022 — Oculogica and Minnetronix announce a partnership to manufacture EyeBOX. Parents with children in sports often worry about concussions. It’s an anxiety …
Oculogica Announces Launch of New EyeBOX® Device
The EyeBOX is the First FDA-cleared Objective Test for Concussion March 1, 2022 — Oculogica, a leader in concussion diagnostics, today announced launch of the new EyeBOX …